• Side Effects of Olverembatinib

  Olverembatinib is a targeted therapy for specific types of leukemia. Common side effects include hematological abnormalities (e.g., anemia, thrombocyt···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 121

• How Many Tablets of Olverembatinib Should Be Taken per Day?

  The daily dosage of olverembatinib must be strictly followed as directed by a physician, typically 40 mg once daily (the specific dosage shall be subj···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 136

• Indications of Olverembatinib

  Olverembatinib is a targeted therapy agent primarily indicated for adult patients with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia ···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 129

• Olverembatinib Tablets

  Olverembatinib is a targeted therapy drug indicated for patients with specific types of leukemia, with olverembatinib as its primary active ingredient···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 114

• Contraindications of Pyrotinib

  The contraindications of pyrotinib mainly involve hypersensitivity to drug components, severe hepatic or renal insufficiency, pregnant and lactating w···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 114

• Important Usage Instructions for Pyrotinib Maleate

  Pyrotinib Maleate is an oral targeted therapy drug primarily indicated for the treatment of HER2-positive breast cancer. Administration must be strict···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 115

• Adverse Reactions of Pyrotinib

  Pyrotinib is a small-molecule targeted drug primarily indicated for the treatment of HER2-positive breast cancer. Its common adverse reactions mainly ···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 123

• How Many Tablets of Pyrotinib Should Be Taken Daily?

  The dosage of pyrotinib must strictly follow the doctor's instructions and is usually adjusted based on the patient's body weight, disease con···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 126

• Indications of Pyrotinib

  Pyrotinib is a small-molecule tyrosine kinase inhibitor (TKI), primarily indicated for the treatment of patients with HER2-positive breast cancer. Cur···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 140

• Package Insert for Pyrotinib

  Pyrotinib is an oral small-molecule tyrosine kinase inhibitor (TKI) primarily indicated for the treatment of HER2-positive breast cancer. It irreversi···【Read More】

  Update: 2026-01-19Source: Haiou HealthViews: 116

• Precautions for the Use of Anlotinib

  Anlotinib is an oral multi-targeted tyrosine kinase inhibitor, primarily indicated for the targeted therapy of specific advanced cancers. To balance t···【Read More】

  Update: 2026-01-16Source: Haiou HealthViews: 116

• Adverse Reactions of Anlotinib

  Anlotinib is an anti-tumor targeted drug. Its common adverse reactions include hypertension, bleeding risk, hand-foot syndrome, proteinuria, and gastr···【Read More】

  Update: 2026-01-16Source: Haiou HealthViews: 129

• Dosage and Administration of Anlotinib

  The recommended dosage of anlotinib is 12 mg once daily, to be administered orally on an empty stomach (no food should be consumed 2 hours before and ···【Read More】

  Update: 2026-01-16Source: Haiou HealthViews: 145

• Indications of Anlotinib

  Anlotinib is an oral small-molecule multi-targeted tyrosine kinase inhibitor, primarily indicated for the treatment of patients with specific advanced···【Read More】

  Update: 2026-01-16Source: Haiou HealthViews: 130

• Anlotinib Hydrochloride Capsules Package Insert

  Anlotinib Hydrochloride Capsules is an antineoplastic agent belonging to the class of multi-targeted receptor tyrosine kinase inhibitors. It exerts it···【Read More】

  Update: 2026-01-16Source: Haiou HealthViews: 127